Pain in Guillain-Barre Syndrome
Neurol 48:328-331, Moulin,D.E.,et al, 1997
Measles Vaccination and Guillain-Barre Syndrome
349:14-16, daSilveira,C.M.,et al, 1997
Appropriate Number of Plasma Exchanges in Guillain-Barre Syndrome
French Coop Grp on Plasma Exchange in GBS, Ann Neurol 41:298-306, 287997., , 1997
Few Psychological Consequences of Presymptomatic Testing for Huntington Disease
Lancet 349:4, Bundey,S., 1997
Autoantibodies to Glutamic Acid Decarboxylase in Three Patients With Cerebellar Ataxia, Late-Onset Insulin-Dependent Diabetes Mellitus, and Polyendocrine Autoimmunity
Neurol 49:1026-1030, Saiz,A.,et al, 1997
Acute Myopathy of Intensive Care:Clinical, Electromyographic, and Pathological Aspects
Ann Neurol 40:645-654, Lacomis,D.,et al, 1996
Charcot-Marie-Tooth Disease and Related Inherited Neuropathies
Medicine 75:233-250, Murakami,T.,et al, 1996
Idiopathic Acute Transverse Myelitis:MR Imaging Findings
Radiology 201:661-669, Tartaglino,L.M.,et al, 1996
Presymptomatic Diagnosis of Neurofibromatosis 2 Using Linked Genetic Markers, Neuroimging, and Ocular Examinations
Neurol 47:1269-1277, Baser,M.E., 1996
Stimulus-Evoked Sinus Arrest in Severe Guillain-Barre Syndrome:A Case Report
Neurol 47:1239-1242, Minahan,R.E.,et al, 1996
Taste Loss as an Initial Symptom of Guillain-Barre Syndrome
Neurol 47:1604-1605, Combarros,O.,et al, 1996
Cavernous Sinus Syndrome
Arch Neurol 53:967-971, Keane,J.R., 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996
Diagnosis of McArdle's Disease by Molecular Genetic Analysis of Blood
Neurol 47:579-580, El-Schahawi,M.,et al, 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Lyme Radiculoneuritis Treated with Intravenous Immunoglobin
Neurol 46:1174-1175, Crisp,D.&Ashby,P., 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996
Autonomic Ganglionitis with Severe Hypertension, Migraine, and Episodic but Fatal Hypotension
Neurol 47:817-821, Lee,H.C.,et al, 1996
Chronic Post-Traumatic Headache Often a Myth
Neurol 46:915-916, Warner,J.S.&Fenichel,G.M., 1996
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Prospective Evaluation of MRI Lumbosacral Nerve Root Enhancement in Acute Guillain-Barre Syndrome
Neurol 47:813-817, Gorson,K.C.,et al, 1996
Intravenous IgG in Guillain-Barre Syndrome
BMJ 313:376-377, Hughes,R.A.C., 1996
Pseudotumor Associated with CNS Lymphoma
J Neuro-Ophthalmol 16:208-211, Hudson,H.L.,et al, 1996
Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996
Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
Childhood Chronic Inflammatory Demyelinating Neuropathies:Clinical Course and Long-term Follow-up
Neurol 47:98-102, Nevo,Y.,et al, 1996
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Hereditary Spastic Paraplegia:Advances in Genetic Research
Neurol 46:1507-1514, Fink,J.K.,et al, 1996
Twelfth-Nerve Palsy:Analysis of 100 Cases
Arch Neurol 53:561-566, Keane,J.R., 1996
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996
Age and Guillain-Barre Syndrome Severity
Muscle & Nerve 19:375-377996., Sheth,R.D.,et al, 1996
Diagnosis of Merosin (Laminin-2) Deficient Congenital Muscular Dystrophy by Skin Biopsy
Lancet 347:582-584, Sewry,C.A.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Diphtheritic Neuropathy
Muscle & Nerve 18:1460-1463995., Greange,A.,et al, 1995
Apolipoprotein E Allele E4, Dementia, and Cognitive Decline in a Population Sample
Lancet 346:1387-1390, Henderson,A.S.,et al, 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Apoliprprotein E E4 Allele & the Lifetime Risk of Alzheimer's Disease:What Physicians Know, & What They Should Know
Arch Neurol 52:1074-1079, Seshadri,S.,et al, 1995
Apolipoprotein E Genotype in Patients with Alzheimer's Disease:Implications for Risk of Dementia Among Relatives
Ann Neurol 38:797-808, Farrer,L.A.,et al, 1995
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995